Sun Pharma sells CNS divisions to Strides Arcolab

Mumbai;Sept 19: Sun Pharmaceutical Industries Ltd. on Saturday said the company has signed agreement with Strides Arcolab Ltd. to sell central nervous system (CNS) portfolio of erstwhile Ranbaxy Laboratories Ltd for Rs1,65 crore.

The agreement involves transfer of two marketing divisions 'Solus' and 'Solus Care', along with employees to Strides, statement from Sun Pharma said.

The transaction is subject to approval from the Competition Commission of India and other customary closing conditions.

"All other terms and conditions of the transaction are confidential," both the companies said in a joint filing with the stock exchanges.

How RBI is disposing of demonetised currency worth Rs 15.28 trillion

New Delhi: Demonetised Rs 500 and Rs 1,000 notes, which have been counted and processed for genuineness, are shredded and briquetted before being disp...

RBI issues corrective framework for PSBs

New Delhi: Amid the multiple scams unearthed recently in the banking sector, the Reserve Bank of India (RBI) has issued a Prompt Corrective Action (PC...

No proposal under consideration to scrap Rs 2,000 note: Government

New Delhi: The government on Friday categorically said there was no proposal to discontinue Rs 2,000 currency note, which was introduced post demoneti...

Odisha govt to set up Information Technology Investment Region

Bhubaneswar: Odisha Chief Minister Naveen Patnaik on Thursday said the government has proposed to set up an Electronics System Design and Manufacturin...